Search

Smith & Nephew PLC

Open

1,316.5 -0.38

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1316

Max

1327.5

Belangrijke statistieken

By Trading Economics

Inkomsten

296M

Verkoop

3B

K/W

Sectorgemiddelde

31.952

22.773

EPS

0.429

Dividendrendement

2.82

Winstmarge

9.895

Werknemers

17,000

EBITDA

723M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+7.78% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.82%

4.44%

Volgende dividenddatum

7 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2.4B

11B

Vorige openingsprijs

1316.88

Vorige sluitingsprijs

1316.5

Smith & Nephew PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 okt 2025, 21:50 UTC

Acquisities, Fusies, Overnames

Caterpillar to Acquire Australia's RPM Global for $730 Million

10 okt 2025, 21:38 UTC

Acquisities, Fusies, Overnames

Strathcona Resources Terminates Take-Over Bid for MEG Energy

12 okt 2025, 23:47 UTC

Marktinformatie

Gold Rises, Buoyed by Monetary Debasement Fears -- Market Talk

12 okt 2025, 23:39 UTC

Marktinformatie

Oil Rises on Likely Technical Recovery, Mildly Positive Sentiment -- Market Talk

12 okt 2025, 23:22 UTC

Marktinformatie

New Zealand Braces For Renewed Trade War Uncertainty -- Market Talk

12 okt 2025, 23:16 UTC

Acquisities, Fusies, Overnames

Caterpillar Inc. Enters Into Agreement To Acquire RPMGlobal >CAT RUL.AU

12 okt 2025, 22:32 UTC

Marktinformatie

Copper, U.S. Thermal Coal Stand Out as Metals Ride Macro Tailwinds -- Market Talk

12 okt 2025, 21:28 UTC

Acquisities, Fusies, Overnames

RPM Global Says Board Unanimously Recommends Shareholders Accept Caterpillar Offer

12 okt 2025, 21:28 UTC

Acquisities, Fusies, Overnames

RPM Global Agrees to Takeover by Caterpillar

12 okt 2025, 21:28 UTC

Acquisities, Fusies, Overnames

RPM Global Says Caterpillar Offering A$5.00/Share in Cash

11 okt 2025, 08:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

11 okt 2025, 00:18 UTC

Acquisities, Fusies, Overnames

Why Biotech May Be Back -- Barrons.com

10 okt 2025, 21:07 UTC

Winsten
Acquisities, Fusies, Overnames

Dell Is Just Beginning to Tell Its AI Story. Buy the Stock. -- Barrons.com

10 okt 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

10 okt 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

10 okt 2025, 20:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

10 okt 2025, 20:06 UTC

Marktinformatie

Fed Won't Publish Monthly Industrial Data Next Week -- Market Talk

10 okt 2025, 20:06 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

10 okt 2025, 19:56 UTC

Marktinformatie

U.S.-China Tension Weighs Down on Treasury Yields, Dollar -- Market Talk

10 okt 2025, 19:20 UTC

Marktinformatie

Oil Futures Sink As Trump Rekindles Trade Tensions -- Market Talk

10 okt 2025, 19:02 UTC

Marktinformatie

U.S. Natural Gas Futures Post Weekly Loss -- Market Talk

10 okt 2025, 18:58 UTC

Marktinformatie

Canada's Jobs Gain Marks a 'Head Fake' For Economy -- Market Talk

10 okt 2025, 18:52 UTC

Marktinformatie

PepsiCo Lays Groundwork for Improvement -- Market Talk

10 okt 2025, 18:47 UTC

Marktinformatie

Precious Metals Turn Higher After Profit-Taking Slide -- Market Talk

10 okt 2025, 18:35 UTC

Marktinformatie

Canada's Next Rate Cut May be Pushed to December -- Market Talk

10 okt 2025, 18:31 UTC

Marktinformatie

Canada's Labor Market Firming. But Conditions Vary Across Country -- Market Talk

10 okt 2025, 17:32 UTC

Marktinformatie

U.S. Oil Rig Count Declines by Four to 418 -- Market Talk

10 okt 2025, 16:55 UTC

Winsten

These Stocks Are Moving the Most Today: MP Materials, Nvidia, Alibaba, Venture Global, Applied Digital, Qualcomm, and More -- Barrons.com

10 okt 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

10 okt 2025, 16:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

Smith & Nephew PLC Prognose

Koersdoel

By TipRanks

7.78% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1,427.55Ā GBXĀ  7.78%

Hoogste 1,700Ā GBX

Laagste 1,250Ā GBX

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Smith & Nephew PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

6

Buy

5

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat